TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2972162

Group type: EXPERIMENTAL
Intervention: 0.5 mg 17 beta‐estradiol cyclo‐octyl acetate (E2COA) + 0.15 mg desogestrel
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2 mg micronized 17 beta‐estradiol (mE2) + 0.15 mg desogestrel
Number of subjects: 8
Study: 29856312

Group type: EXPERIMENTAL
Intervention: Enhanced psychological care (EPC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual cardiac rehabilitation care (UC)
Number of subjects: 29
Study: 28115329

Group type: EXPERIMENTAL
Intervention: Ex vivo normothermic perfusion (EVNP)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Static cold storage
Number of subjects: 400
Study: 24378148

Group type: EXPERIMENTAL
Intervention: Arm-cranking exercise (12 weeks, 3 sessions/week)
Number of subjects: 17
Study: 23298985

Group type: EXPERIMENTAL
Intervention: Siblings Are Special (SIBS) program
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 174
Study: 21467235

Group type: EXPERIMENTAL
Intervention: Plasma CoQ(10) levels
Number of subjects: 993
Study: 17429754

Group type: EXPERIMENTAL
Intervention: Accelerated protocol (progressive doses of Dobutamine with early atropine administration)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional protocol (progressive doses of Dobutamine with late atropine administration)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Accelerated protocol
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional protocol
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 168
Study: 16493215

Group type: EXPERIMENTAL
Intervention: Plasmakinetic resection (PK)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard monopolar TURP
Number of subjects: 48
Study: 12943958

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Classical mood stabilizers
Number of subjects: 28
Study: 11131082

Group type: EXPERIMENTAL
Intervention: Advanced practice gerontological nurses (APNs)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 197
Study: 9364249

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sick/normal FTI
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sick/low FTI
Number of subjects: 34
Study: 1494189

Group type: EXPERIMENTAL
Intervention: Lidocaine 0.5% with epinephrine (Group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal saline (Group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No injections (Group III, Control)
Number of subjects: 0
Study: 30858305

Group type: EXPERIMENTAL
Intervention: WISENSE
Number of subjects: 324

Group type: COMPARATOR
Intervention: Control
Number of subjects: 324
Study: 27940314

Group type: EXPERIMENTAL
Intervention: Permissive parenting
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Parental monitoring
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Restriction
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Authoritarian parenting
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Monitoring child dietary intake
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Restriction of child dietary intake
Number of subjects: 421
Study: 26002807

Group type: EXPERIMENTAL
Intervention: Long-acting reversible contraception (LARCs)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Other prescription methods (primarily oral contraceptives)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Nonprescription methods (primarily condoms)
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: No method
Number of subjects: 987
Study: 23103177

Group type: EXPERIMENTAL
Intervention: High-dose rifampicin (600 mg, about 13 mg/kg) intravenously
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose rifampicin (450 mg, about 10 mg/kg) orally
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 800 mg once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ethambutol 750 mg once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard-dose isoniazid, pyrazinamide, and adjunctive corticosteroids
Number of subjects: 60
Study: 21402649

Group type: EXPERIMENTAL
Intervention: Experimental group engaged in standing, static balancing, and mild leg exercise 12 minutes per session, three times per week for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group given literature on prevention of falls
Number of subjects: 25
Study: 18805656

Group type: EXPERIMENTAL
Intervention: buprenorphine-naloxone
Number of subjects: 344

Group type: COMPARATOR
Intervention: clonidine
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: inpatient setting
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: tobacco use
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: severe baseline anxiety symptoms
Number of subjects: 344
Study: 16682586

Group type: EXPERIMENTAL
Intervention: Macular grid laser photocoagulation after intravitreal injection of 4 mg of triamcinolone acetonide (IVTA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intravitreal injection of 4 mg of triamcinolone acetonide (IVTA) only
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Macular grid laser photocoagulation after IVTA
Number of subjects: 74
Study: 15498091

Group type: EXPERIMENTAL
Intervention: WHO definition of metabolic syndrome
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: NCEP definition of metabolic syndrome
Number of subjects: 917

Group type: COMPARATOR
Intervention: Comparison of WHO and NCEP definitions
Number of subjects: 917

Group type: COMPARATOR
Intervention: Mean values of waist circumference, BMI, triglycerides, HDL cholesterol
Number of subjects: 917
Study: 11729015

Group type: EXPERIMENTAL
Intervention: Emotion-focused psychotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cognitive behavior therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 30
Study: 9387944

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (400 mg x day(-1))
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8203989

Group type: EXPERIMENTAL
Intervention: Voucher for a free screening mammogram
Number of subjects: 119

Group type: COMPARATOR
Intervention: No voucher for screening mammogram
Number of subjects: 119
Study: 3669768

Group type: COMPARATOR
Intervention: High dose CVP (cyclophosphamide 1500 mg/m2 i.v. day 1, vincristine 1.4 mg/m2 day 1, and prednisone 40 mg/m2 orally days 1‐10)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: High dose CAVP (cyclophosphamide 1000 mg/m2 i.v. day 1, doxorubicin 45 mg/m2 i.v. day 1, vincristine and prednisone as above)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: High dose CAVP
Number of subjects: 93

Group type: COMPARATOR
Intervention: High dose CVP and CAVP
Number of subjects: 93
Study: 29307683

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg regularly twice per week for 3 months immediately after urethral catheter removal
Number of subjects: 120

Group type: COMPARATOR
Intervention: Delayed treatment with sildenafil starting 3 months after surgery
Number of subjects: 120
Study: 27614077

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA)
Number of subjects: 934
Study: 23873981

Group type: EXPERIMENTAL
Intervention: Training for GPs
Number of subjects: 49
Study: 23150906

Group type: EXPERIMENTAL
Intervention: Primary care dedicated inpatient rehabilitation (PCDIR)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Primary care nursing home rehabilitation (PCNHR)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: PCDIR
Number of subjects: 302
Study: 21423852

Group type: EXPERIMENTAL
Intervention: MTZ 500 mg twice a day for 7 days
Number of subjects: 270

Group type: COMPARATOR
Intervention: MTZ 2-gm single dose
Number of subjects: 270
Study: 18278532

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (SNS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Best supportive therapy (control)
Number of subjects: 120
Study: 16271721

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous ergometrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular oxytocin
Number of subjects: 0
Study: 12840615

Group type: EXPERIMENTAL
Intervention: High spousal solicitousness in males
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: High spousal solicitousness in females
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Spousal solicitousness in both genders
Number of subjects: 327
Study: 10374157

Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified (HSM) intraocular lenses (IOLs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unmodified poly(methyl methacrylate) (PMMA) IOL
Number of subjects: 90
Study: 8894357

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d. for 4 weeks (patients with PUD)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d. for 4 weeks (patients without PUD)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo for 4 weeks (patients without PUD)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Minor mucosal lesions (Ranitidine vs Placebo)
Number of subjects: 124
Study: 1814841

Group type: EXPERIMENTAL
Intervention: Ofloxacin 50 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ofloxacin 100 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ofloxacin 400 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ofloxacin 50 to 200 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 6402540

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30946953

Group type: EXPERIMENTAL
Intervention: Conventional TENS (high-frequency, low-intensity)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (low-frequency, high-intensity)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 80
Study: 28864706

Group type: EXPERIMENTAL
Intervention: Escalating with reset contingency management (CM) as an adjunct to standard smoking cessation treatment over a 5-week period
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard smoking cessation treatment
Number of subjects: 40
Study: 26530856

Group type: EXPERIMENTAL
Intervention: Preventive interventions (surgery, embolization, radiation therapy, alone or combined)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Pre-surgical or pre-radiation embolization
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 2000

Group type: COMPARATOR
Intervention: No embolization
Number of subjects: 2000
Study: 23374528

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (F)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sutures (S)
Number of subjects: 10
Study: 21126997

Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV)
Number of subjects: 27
Study: 20137481

Group type: EXPERIMENTAL
Intervention: Venlafaxine treatment for 8 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TRD patients
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NTRD patients
Number of subjects: 50
Study: 17519218

Group type: EXPERIMENTAL
Intervention: TW UV‐B
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: SW UV‐B
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: Bath PUVA
Number of subjects: 1241
Study: 12911449

Group type: EXPERIMENTAL
Intervention: Kliogest
Number of subjects: 120
Study: 10678578

Group type: EXPERIMENTAL
Intervention: Microspot CO2 laser excision
Number of subjects: 37

Group type: COMPARATOR
Intervention: Microdissection
Number of subjects: 37
Study: 9070591

Group type: EXPERIMENTAL
Intervention: TPM 1,000 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: TPM 100 mg/day
Number of subjects: 48
Study: 8444274

Group type: COMPARATOR
Intervention: Jejunal infusion of 1.3 kcal min‐1 (5.5 kJ min‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Jejunal infusion of 3.3 kcal min‐1 (14.0 kJ min‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study: 3098132

Group type: EXPERIMENTAL
Intervention: 2% nitroglycerin ointment applied to the forehead 12 minutes prior to intubation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no nitroglycerin ointment)
Number of subjects: 56
Study: 31757717

Group type: COMPARATOR
Intervention: Sutures plus chlorhexidine gluconate (CHG) dressing (standard care)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Standard care plus tissue adhesive (TA)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Two sutureless stabilisation devices (SSD) plus CHG dressing
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Sutures, CHG disc plus integrated securement dressing (ISD)
Number of subjects: 121
Study: 30453487

Group type: EXPERIMENTAL
Intervention: Test yogurt enriched with Lactococcus lactis 11/19-B1 and Bifidobacterium lactis BB-12, 80 g daily for 8 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control yogurt fermented with Streptococcus thermophiles, Lactobacillus delbrueckii subspecies bulgaricus, and Lactobacillus acidophilus, 80 g daily for 8 weeks
Number of subjects: 76
Study: 26723083

Group type: EXPERIMENTAL
Intervention: Anti-thymocyte globulin (ATG) 4.5 mg/kg intravenously over 3 days (0.5 mg/kg 2 days before transplantation, 2.0 mg/kg 1 day before, and 2.0 mg/kg 1 day after)
Number of subjects: 203

Group type: COMPARATOR
Intervention: No anti-thymocyte globulin (no ATG)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Anti-thymocyte globulin (ATG)
Number of subjects: 203
Study: 24113319

Group type: EXPERIMENTAL
Intervention: Supervised exercise training (6 months of supervised exercise followed by 6 months of home-based maintenance)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Printed educational material about physical activity (control group)
Number of subjects: 100
Study: 22749600

Group type: EXPERIMENTAL
Intervention: MVA85A vaccine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study: 20400411

Group type: EXPERIMENTAL
Intervention: Vicriviroc (VCV) 5, 10, or 15 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 18324565

Group type: EXPERIMENTAL
Intervention: Smokers aged 50+
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smokers aged <50
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women aged 50+
Number of subjects: 0

Group type: COMPARATOR
Intervention: Men aged <50
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both age groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older smokers
Number of subjects: 0
Study: 15973115

Group type: EXPERIMENTAL
Intervention: 5‐ASA 500 mg suppository (Canasa; Axcan Pharma) BID
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 5‐ASA 1 g at bedtime (HS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study: 14636777

Group type: EXPERIMENTAL
Intervention: Antiepileptic treatment for transitory cognitive impairment (TCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10610747

Group type: EXPERIMENTAL
Intervention: Red wine with alcohol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: De-alcoholized red wine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (before drinking)
Number of subjects: 12
Study: 8633817

Group type: EXPERIMENTAL
Intervention: 3600 mg saquinavir per day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 7200 mg saquinavir per day
Number of subjects: 40
Study: 9259838

Group type: EXPERIMENTAL
Intervention: Antithrombin replacement therapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 132
Study: 6414283

Group type: EXPERIMENTAL
Intervention: Commercial starch blocker
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31443654

Group type: EXPERIMENTAL
Intervention: Single-dose azithromycin (20 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30119697

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill training (60-80% of heart rate reserve)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Walking outside (control group, below 40% of heart rate reserve)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Walking outside (control group)
Number of subjects: 22
Study: 27267950

Group type: EXPERIMENTAL
Intervention: Short sleep (6h/night)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Long sleep (9h/night)
Number of subjects: 34
Study: 24708443

Group type: EXPERIMENTAL
Intervention: Long-term oral corticosteroids (LTOC)
Number of subjects: 444
Study: 21643774

Group type: EXPERIMENTAL
Intervention: V0355 (80 mg Fe/day)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Ferrograd® (105 mg Fe/day)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: V0355
Number of subjects: 399

Group type: COMPARATOR
Intervention: Ferrograd®
Number of subjects: 399
Study: 20006642

Group type: EXPERIMENTAL
Intervention: Self-help plus telephone counseling (SH+C)
Number of subjects: 2470

Group type: COMPARATOR
Intervention: Self-help (SH)
Number of subjects: 2470
Study: 17363762

Group type: EXPERIMENTAL
Intervention: BIS-reactivity measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BAS-reactivity measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impulsivity measures
Number of subjects: 0
Study: 16326661

Group type: EXPERIMENTAL
Intervention: Multimedia support program delivered over the Internet (Caregiver's Friend: Dealing with Dementia)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 299
Study: 11914399

Group type: EXPERIMENTAL
Intervention: Immediate surgery (unilateral posterior pallidotomy)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Immediate surgery (unilateral posterior pallidotomy) with left lesions
Number of subjects: 33

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: History of depression
Number of subjects: 33
Study: 9808644

Group type: EXPERIMENTAL
Intervention: 720 mL/d of apple juice containing 5 g of gum arabic and pectin (4:1 ratio)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 720 mL/d of apple juice containing 9 g of gum arabic and pectin (4:1 ratio)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 720 mL/d of apple juice containing 15 g of gum arabic and pectin (4:1 ratio)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 720 mL/d of apple juice (control)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Washout phase (apple juice only)
Number of subjects: 110
Study: 7631621

Group type: EXPERIMENTAL
Intervention: bisoprolol (2.5 to 10 mg) with 6.25 mg of hydrochlorothiazide (HCTZ)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: amlodipine (2.5 to 10 mg)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: enalapril (5 to 20 mg)
Number of subjects: 218
Study: 2360544

Group type: EXPERIMENTAL
Intervention: Selenomethionine (200 micrograms/d for 3 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inorganic selenite (200 micrograms/d for 3 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selenium from deep body pools
Number of subjects: 0
Study: 7346529

Group type: EXPERIMENTAL
Intervention: H-1 antagonist hydroxyzine
Number of subjects: 13

Group type: COMPARATOR
Intervention: H-2 antagonist cimetidine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Combination of H-1 and H-2 antagonists
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Hydroxyzine alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Cimetidine alone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Hydroxyzine plus cimetidine
Number of subjects: 13
Study: 31305270

Group type: EXPERIMENTAL
Intervention: Pertuzumab (840 mg loading dose followed by 420 mg maintenance doses every 3 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pertuzumab (in combination with trastuzumab)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pertuzumab
Number of subjects: 15
Study: 27025843

Group type: EXPERIMENTAL
Intervention: IV aminophylline (100 mg administered over 30-60 seconds)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: IV caffeine citrate (60 mg infused over 3-5 minutes)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PO caffeine (as coffee or diet cola)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: PO caffeine
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: IV aminophylline and IV caffeine
Number of subjects: 241
Study: 27132456

Group type: EXPERIMENTAL
Intervention: Small incision combined with percutaneous tracheostomy (small puncture incision group, n = 25)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional tracheostomy (control group, n = 32)
Number of subjects: 57
Study: 24647226

Group type: EXPERIMENTAL
Intervention: Novel disposable circumcision device (Device Group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional dissection technique (Control Group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 22730040

Group type: EXPERIMENTAL
Intervention: Risperidone plus dextromethorphan (Risp+ DM)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Risperidone (Risp) only
Number of subjects: 95
Study: 19786379

Group type: EXPERIMENTAL
Intervention: 6 mg lutein/d
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 12 mg lutein/d
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37